title: Roundtable discussion. Optimizing the use of antimicrobial therapy.
authors.forename: W
authors.initials: W
authors.lastname: Bishai
authors.forename: A B
authors.initials: AB
authors.lastname: Brueggemann
authors.forename: D P
authors.initials: DP
authors.lastname: Nicolau
authors.forename: I
authors.initials: I
authors.lastname: Steinberg
authors.forename: E
authors.initials: E
authors.lastname: Spiritus
authors.forename: C
authors.initials: C
authors.lastname: Tanigawa
authors.forename: S
authors.initials: S
authors.lastname: Koenig
authors.forename: R E
authors.initials: RE
authors.lastname: Chaisson
authors.forename: B A
authors.initials: BA
authors.lastname: Browne
authors.forename: D M
authors.initials: DM
authors.lastname: Yoder
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial / Q000235:genetics; D017850:Economics, Pharmaceutical; D006801:Humans; D007902:Length of Stay; D017410:Practice Guidelines as Topic; D014481:United States
chemical_list: D000900:Anti-Bacterial Agents